Skip to main content
. 2018 Dec 28;8(1):e011343. doi: 10.1161/JAHA.118.011343

Figure 4.

Figure 4

Medications that can augment the BMPR2 pathway as a therapeutic strategy for PAH. BMPR2 indicates bone morphogenic protein receptor 2; DHEA, dehydroepiandrosterone; FKBP12, 12‐kDa FK506‐binding protein; FOXO1, forkhead box protein O1; STAT3, signal transducer and activator of transcription 3; TNF‐α, tumor necrosis factor‐α.